KalVista Pharma appoints Edward P. Feener as CSO
Dr. Feener has more than 27 years of research experience in vascular biology and diabetic complications, contributing to more than 80 scientific publications during his career.
Prior to taking his new role at KalVista, he was an Associate Professor of Medicine at Harvard Medical School and Senior Investigator in the Section on Vascular Cell Biology at the Joslin Diabetes Center, a research and clinical affiliate of Harvard Medical School.
Dr. Feener received his Ph.D. in Biochemistry from Boston University and completed postdoctoral training at the Joslin Center and Harvard Medical School. ■
LATEST MOVES FROM
More inside POST
DSW Q1 sales increased 1.4% Earnings